Annual Secretarial Compliance Report for the year ended 31-03-2026 is enclosed herewith
KPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Kwality Pharmaceuticals has submitted its Annual Secretarial Compliance Report for FY2025-26, certified by Practicing Company Secretaries M/s Rishi Mittal & Associates. The report confirms full compliance with all SEBI regulations including LODR, PIT, Depositories, and Takeover Regulations. All 13 compliance checkpoints including secretarial standards, board evaluations, related party transactions, and website disclosures received clean status. The company had no current-period deviations. A previous one-day delay in XBRL submission of the FY2023-24 report to BSE resulted in a Rs.2,360 penalty, which has been paid and resolved.
A clean secretarial compliance report with no current violations is positive for investor confidence, indicating strong adherence to SEBI governance and disclosure requirements with no outstanding regulatory concerns.